Accelerating Innovation: Complexity, Regulation, and Temporality.

Area of Science:

• Biomedical innovation
• Regulatory science
• Health policy

Background:

• Global trend towards accelerating biomedical innovation delivery to clinical settings.
• Regenerative medicine serves as a key example of these shifts.
• Existing regulatory and innovation paradigms are being reconfigured.

Purpose of the Study:

• To explore the drivers and rationale behind accelerated biomedical innovation.
• To analyze the reconfiguration of present/future relations in evidence and risk calculations.
• To examine the evolving relationship between regulation and innovation.

Main Methods:

• Perspective paper analyzing recent trends in biomedical innovation.
• Discussion of theoretical frameworks, including "science-in-the-making."
• Case illustration using regenerative medicine.

Main Results:

• Acceleration is driven by innovation complexity, not streamlined evaluation.
• "Science-in-the-making" is now highly visible, alongside "regulation-in-the-making" and "risk-in-the-making."
• The process fundamentally alters how evidence and risk are calculated and managed.

Conclusions:

• The acceleration of biomedical innovation necessitates a rewriting of the regulatory/innovation relationship.
• Understanding "in-the-making" processes is crucial for future oversight.
• Strategic engagement with these shifts is required for effective innovation management.